Effect of Ruboxistaurin on the Visual Acuity Decline Associated with Long-standing Diabetic Macular Edema | Zendy

Matthew D. Davis | Zendy; Matthew J. Sheetz | Zendy; Lloyd Paul Aiello | Zendy; Roy C. Milton | Zendy; Ronald P. Danis | Zendy; Xin Zhi | Zendy; Aniz Girach | Zendy; María Cristina Hernández Jiménez | Zendy; Louis Vignati | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Ruboxistaurin on the Visual Acuity Decline Associated with Long-standing Diabetic Macular Edema

Author(s) -

Matthew D. Davis,

Matthew J. Sheetz,

Lloyd Paul Aiello,

Roy C. Milton,

Ronald P. Danis,

Xin Zhi,

Aniz Girach,

María Cristina Hernández Jiménez,

Louis Vignati

Publication year - 2009

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.08-2473

Subject(s) - medicine , diabetic retinopathy , ophthalmology , placebo , fundus (uterus) , visual acuity , diabetes mellitus , diabetic macular edema , macular edema , endocrinology , alternative medicine , pathology

To compare relationships between severity and duration of diabetic macular edema (DME) and visual acuity (VA) observed in the PKC-DRS2 with those from the Early Treatment Diabetic Retinopathy Study (ETDRS) and to assess the effect of the orally administered PKC beta inhibitor ruboxistaurin (RBX) on these parameters.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research